The present study is a placebo- controlled, single-blind sequential study. Total of 40 males aged between ≥ 18 years and ≤35 years will be screened. Assuming screen failure and dropout rate in this study, a minimum of 30 participants should complete the study. The treatment duration for all the study participants will be 60 days.

Inclusion Criteria:

• Males aged ≥18 to ≤ 35 years with moderate physical activity levels as per International Physical Activity Questionnaire (IPAQ-SF).
• Occasionally gym goer with a history of at least 1 month of training but not participating in the resistance-type activity for ≥3 months.
• Habitual non-veg eater
• Body mass index (BMI) 22 - 29.9 kg/ m2
• Waist Circumference 94-102 cm
• Ready to refrain from caffeinated products and intense strength/ endurance exercise for 24 hrs before the exercise lab visit.
• Fasting blood Glucose ≤ 125 mg/ dl
• Systolic Blood Pressure ≤ 129 mm Hg and Diastolic Blood Pressure ≤ 89 mm Hg
• TSH (thyroid stimulating hormone) ≥0.4 and ≤ 4.9 mIU/L

Exclusion Criteria:

• Engaged in structured weight training for more than 12 months before screening.
• Presence of chronic disease
• Changes in body weight of more than 4.5 kg (10 pounds) in the past three months
• Individuals with uncontrolled hypertension
• Known cases of Type II Diabetes mellitus
• History or presence of clinically significant renal, hepatic, endocrine, biliary, gastrointestinal, pancreatic, or neurologic disorders
• Individuals who have any other disease or condition or are using any medication that, in the investigator's judgment would put them at unacceptable risk for participation in the study or may interfere with evaluations or non-compliance with treatment or visits
• Individuals who have been part of a clinical trial within 90 days before the screening
• Individuals who have used whey or other supplements anytime in the last 3 months